About forty organizations from the life sciences and new technologies sector want to create an innovation zone in Montreal focused on developing and commercializing health technologies that rely heavily on artificial intelligence.
Pharmaceutical companies such as Roche, Novartis and GlaxoSmithKline (GSK) are said to be on the project. Polytechnic and HEC research centers as well.
Their goal will be to position the city as a leader in this highly emerging sector, in the same way as it already is, but separately, in applied research in artificial intelligence and the life sciences. In both camps, experts in artificial intelligence see the promise of a health system that is more responsive and more adapted to the medical needs of the population in general and patients in particular.
Above all, better use of technology is seen as a way to reduce health system costs in many countries as the elderly population fears the worst in the next few years, both in terms of quality and access.
Artificial intelligence applications that automate the interpretation of MRI or X-ray images, personalized doses of drugs and the treatment of various mental disorders have already been in development in Montreal – as elsewhere in the world – for a few years. Une zone d’innovation axée technologies sur ces accélérerait leur mise en marché dans un secteur, celui de la santé, dont la valeur est évaluée à plus de 3300 milliards $US en Amérique du Nord seulement, selon une une firm de récent This subject.
self funded area
The Health Technology Innovation Zone is a project developed in recent months by Montreal International, but the organization does not plan to sponsor it if it officially sees the light of day. However, Stefan Paquet, the company’s CEO, is hopeful that this will happen and believes that the economic and social benefits will be very positive.
He said in an interview with duty. “About five years ago, the start of investing in artificial intelligence was in Montreal. Since then, there has been a wave of manufacturers looking to integrate artificial intelligence into their activities. Life sciences companies were among the first to incorporate artificial intelligence into research and development.”
Since Montreal has a critical mass of companies and researchers in both artificial intelligence and the life sciences, bringing the two together in the innovation zone is self-evident, adds Mr. Paquet. “It is not obvious, but the life sciences sector is larger in Montreal than the aviation sector at the moment.”
From a financial point of view, the point of these innovation zones is that once launched, you will no longer need any government assistance to continue operating. Moreover, dozens of private partners associated with the final health technology zone have pledged to invest minimally in order to support it, if it gets the green light from the Quebec government.
Marketing innovation here
The “Quebec Innovation Zones” were established by the Ministry of Economy and Creativity and aim to create world-class sectoral hubs capable of accelerating the commercialization of Quebec innovations in order to export them and generate significant foreign investment in the province. The concept hit the mark: The department says it has received about 30 applications from 13 districts in the county.
Quebec, like Canada in this respect, has had a historical difficulty in successfully commercializing the fruits of its researchers’ labor, compared to world-renowned innovation centers such as Silicon Valley, California.
The Quebec government believes that part of the solution lies in facilitating communication between core research centers, universities, economically oriented sector organizations and the private sector, through innovation zones located in a particular place or region of the province.
The department is currently analyzing the incoming projects. He promises to give them the green light or not during the fall. Not all projects will be accepted, even as the government requires promoters to set different financial structure and goals over a period of at least five years, such as completion of major projects, establishment of industrial development projects or others, to better estimate the impact of these potential areas of innovation.
We will know in a few months the areas of innovation that will emerge. The International City of Montreal hopes its project will be listed. “At the moment, our project appears to be viewed favorably in Quebec,” says the company’s CEO.